NCR Atleos (NYSE:NATL – Get Free Report)‘s stock had its “outperform” rating reissued by stock analysts at Wedbush in a research note issued to investors on Friday,RTT News reports. They presently have a $45.00 price objective on the stock. Wedbush’s price objective would indicate a potential upside of 26.76% from the stock’s current price. NATL […]

Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Wedbush in a research note issued to investors on Friday,RTT News reports. They presently have a $76.00 price objective on the stock. Wedbush’s price objective would indicate a potential upside of 187.01% from the stock’s current price. Several […]